BRILINTA FDA approval: A major step in reducing stroke risks in acute ischemic stroke and high-risk TIA patients
AstraZeneca has secured U.S. Food and Drug Administration (FDA) approval for BRILINTA (ticagrelor), expanding its use to reduce the risk of stroke in patients suffering ... Read More
Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets, each having 81mg strength. Dr. Wayne’s Aspirin ... Read More
Aspirin no longer recommended for preventing heart attack or stroke in older adults
A seven-year study has found that daily aspirin intake does not lower the risk of heart attack or stroke in older adults, nor does it ... Read More